Cellectar Biosciences (CLRB)
(Delayed Data from NSDQ)
$2.07 USD
-0.04 (-1.90%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $2.08 +0.01 (0.48%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: BMO |
6/2024 | $-0.23 | 0.00% |
Earnings Summary
For their last quarter, Cellectar Biosciences (CLRB) reported earnings of -$0.40 per share, beating the Zacks Consensus Estimate of $-0.50 per share. This reflects a positive earnings surprise of 20.00%. Look out for CLRB's next earnings release on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.23 per share, reflecting a year-over-year increase of 68.49%.
Earnings History
Price & Consensus
Zacks News for CLRB
What's in Store for Cooper Companies (COO) in Q3 Earnings?
CLRB: What are Zacks experts saying now?
Zacks Private Portfolio Services